We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

S32:ASXSouth32 Ltd. Analysis

Data as of 2026-05-17 - not real-time

A$4.21

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

South32 is trading below its short‑term moving averages, with the current price under the 20‑day and 50‑day SMAs, while still sitting above the long‑term SMA, indicating a neutral to slightly bearish technical stance. The RSI hovers in the mid‑40s and the MACD histogram shows a modest bullish signal, suggesting limited upside momentum. Fundamental metrics reveal a price well above the DCF‑derived fair value and a trailing PE that is markedly high, yet forward earnings expectations compress the PE to a more attractive level. The company’s dividend yield remains around 2 % but the payout ratio approaches 70 % amid negative free cash flow, raising concerns about sustainability. Recent news flags trade friction, rising inflation, higher steel costs and contractor underperformance, which have pressured sentiment and contributed to the share’s recent decline. Despite a high volatility environment and a beta below the market, the balance sheet shows cash roughly equal to debt, though leverage appears elevated relative to equity. Overall, the stock sits at a crossroads between short‑term pressure from operational challenges and medium‑term upside from improving earnings forecasts and diversified commodity exposure.
Investors should weigh the overvaluation against the potential earnings rebound and dividend considerations, while remaining mindful of sector cyclicality and the company’s debt profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term SMAs and recent negative commodity‑related news
  • High trailing PE and price above DCF fair value
  • Elevated volatility and modest bullish MACD signal

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Forward PE compression indicating earnings recovery
  • Diversified asset base across multiple commodities and regions
  • Debt level near cash balances but still high relative to equity

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Long‑term commodity demand supporting cash flow generation
  • Attractive dividend yield if cash conversion improves
  • Potential upside if price realigns with DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-2.60%
Profit Margin5.37%
P/E Ratio35.1
ROE4.24%
ROA3.37%
Debt/Equity18.25
P/B Ratio1.5
Op. Cash FlowA$1.4B
Free Cash FlowA$-141124992

Technical Analysis

TrendNeutral
RSI46.2
SupportA$3.80
ResistanceA$4.54
MA 20A$4.27
MA 50A$4.31
MA 200A$3.64
MACDBullish
VolumeStable
Fear & Greed Index88.52

Valuation

Fair ValueA$2.93
Target PriceA$4.67
Upside/Downside11.00%
GradeOvervalued
TypeBlend
Dividend Yield2.24%

Risk Assessment

Beta0.73
Volatility35.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.